SCHEMBL6583705

SCHEMBL6583705

C1=NCCN1Nc1cc2ccccc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HRH3 Q9Y5N1 2/20 0.36
AOC3 Q16853 2/20 0.36
HRH4 Q9H3N8 3/20 0.35
KDM4E B2RXH2 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP3 P42574 1/20 0.34
KMT2A Q03164 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6503147 0.74 HRH3 (0.46) POLBSMN1; SMN2HRH3AOC3HRH4
SCHEMBL11784173 0.73 TSHR (0.48) POLBSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL1307494 0.72 AOC3 (0.38) POLBSMN1; SMN2HRH3AOC3HRH4
SCHEMBL9751584 0.70 L3MBTL1 (0.37) HRH4MEN1CYP2C19KMT2ALOXL2
SCHEMBL1036360 0.70 LMNA (0.34) POLBALDH1A1CYP1A2MAPTCYP2C9
SCHEMBL27075383 0.68 AOC3 (0.52) SMN1; SMN2AOC3KDM4ENPC1RAB9A
SCHEMBL7841603 0.68 NCF1 (0.47) SMN1; SMN2HRH3HRH4KDM4ENPC1
SCHEMBL8304928 0.68 ADRA2A (0.48) KDM4EALDH1A1HPGDAURKA
SCHEMBL7099438 0.68 KDM4E (0.48) POLBSMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL8792860 0.67 FLT3 (0.43) HRH3AOC3HRH4KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944621-B1 2-IMIDAZOLINYLAMINOINDOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS PROCTER & GAMBLE (US) 2004-09-01 EP disclosed
CN-1092652-C 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists PROCTER & GAMBLE (US) 2002-10-16 CN disclosed
US-6395764-B1 NOSAL DECONGESTION, RESPIRATORY SYSTEM DISORDERS THE PROCTER & GAMBLE COMPANY 2002-05-28 US disclosed
US-6395764-B1 NOSAL DECONGESTION, RESPIRATORY SYSTEM DISORDERS THE PROCTER & GAMBLE COMPANY 2002-05-28 US disclosed
US-6162818-A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists THE PROCTER & GAMBLE COMPANY (US) 2000-12-19 US disclosed
US-6162818-A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists THE PROCTER & GAMBLE COMPANY (US) 2000-12-19 US disclosed
CN-1238771-A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists PROCTER & GAMBLE (US) 1999-12-15 CN disclosed
EP-0944621-A1 2-IMIDAZOLINYLAMINOINDOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1999-09-29 EP disclosed
WO-1998023610-A1 2-IMIDAZOLINYLAMINOINDOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 WO disclosed